CNS Pharmaceuticals, Inc. (CNSP) Net income 2018–2025
CNS Pharmaceuticals, Inc. (CNSP) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$15.9MFY2025 · since FY2018: -$7.4M → -$15.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$15.9M | -6.7% |
| FY2024 | -$14.9M | +21.2% |
| FY2023 | -$18.9M | -23.4% |
| FY2022 | -$15.3M | -5.4% |
| FY2021 | -$14.5M | -53.3% |
| FY2020 | -$9.5M | -143.9% |
| FY2019 | -$3.9M | +47.5% |
| FY2018 | -$7.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CNSP financial trends
CNSP RevenueCNSP Net marginCNSP Gross profitCNSP Gross marginCNSP Operating incomeCNSP Operating marginCNSP Operating cash flowCNSP Free cash flowCNSP Capital expendituresCNSP Return on equityCNSP Stock buybacksCNSP Dividends paidCNSP Total assetsCNSP Total liabilitiesCNSP Shareholders’ equityCNSP overview →